Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study

Fig. 2

Mendelian randomization estimates of genome-wide and NPR3-predicted height on cardiovascular disease risk overall and across subtypes. Mendelian randomization estimates are scaled per standard deviation (9.2 cm) greater height. An asterisk denotes p < 0.05. CAD, coronary artery disease; CI, confidence interval; CVD, cardiovascular disease (reflects a pooled CAD, heart failure and stroke effect estimate); NPR3, natriuretic peptide receptor 3

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us